Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by carduon Feb 04, 2006 9:54am
306 Views
Post# 10311494

The need for a cure gets more crucial

The need for a cure gets more crucialCancer cases 'could double by 2020' Press Association Saturday February 4, 2006 12:38 PM Campaigners have urged the world to get serious about cancer prevention, with the disease predicted to surge in the next 15 years. The Association for International Cancer Research (AICR) said that if current trends continue, the number of people developing cancer was set to rise at an "alarming" rate. The UK charity's warning came as countries around the globe marked World Cancer Day. The World Health Organisation predicts that cases of cancer will increase by up to 50% worldwide, with 16 million people developing the disease and 10 million dying from it by 2020. From a total of 58 million deaths worldwide in 2005, cancer accounted for 7.6 million - 13% - of all deaths. But more than a third of cancer cases are thought to be preventable with the help of proper education and public health initiatives. The AICR said that tobacco was "public enemy number one", with diet, poverty and infections also major factors. The charity called on governments to introduce effective health strategies and for people to lead a healthier lifestyle for themselves and their families. Dr Mark Matfield, AICR's scientific director, said: "Around the world we have it in our power to change the cancer picture in a generation and prevention is the key. "Simple steps like giving up tobacco, a healthier diet, more exercise, sun protection and greater use of screening programmes will stem the rise and could save hundreds of thousands - possibly even millions of lives." © Copyright Press Association
Bullboard Posts